Gut Microbiome Studies in Patients With POEMS Syndrome and Other Plasma Cell Disorders

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

A Study to Evaluate Gut Microbiome with POEMS Syndrome and Other Plasma Cell Disorders

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Diagnosed with POEMS syndrome (newly diagnosed or in remission) or with newly diagnosed multiple myeloma (MM), monoclonal gammopathy of undetermined significance (MGUS), amyloid light chain (AL) amyloidosis or healthy controls from their households

Locations
United States
Minnesota
Mayo Clinic in Rochester
RECRUITING
Rochester
Contact Information
Primary
Laura Hawkins
hawkins.laura@mayo.edu
507-538-1308
Backup
Sarah Aug
aug.sarah@mayo.edu
507538-1301
Time Frame
Start Date: 2021-12-29
Estimated Completion Date: 2028-12-29
Participants
Target number of participants: 240
Treatments
MULTIPLE MYELOMA at diagnosis GROUP
Multiple myeloma (before starting chemotherapy, radiation or stem cell transplant
Amyloid at diagnosis GROUP
AL amyloidosis (before starting chemotherapy or stem cell transplant)
Poems at diagnosis GROUP
POEMS at diagnosis (before starting chemotherapy, radiation, or stem cell transplant
Poems in Remission GROUP
POEMS in remission (no chemotherapy, radiation, or stem cell transplant for 2 years
MGUS GROUP
MGUS -not treated newly diagnosed
Health controls in same household GROUP
household member to be a healthy control (no chemotherapy or gastrointestinal illness to participate)
Related Therapeutic Areas
Sponsors
Leads: Mayo Clinic

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

We couldn't find any related articles check for more on the main search page.